Nycomed GmbH

Sepracor Granted Patent Term Extension for LUNESTA[R] and Provides Update on LUNESTA Pediatric Studies.
Business Wire; 12/17/2009; 1070 words; ...XOPENEX HFA and BROVANA are registered trademarks of Sepracor Inc. OMNARIS and ALVESCO are registered trademarks of Nycomed GmbH. For a copy of this release or any recent release, visit Sepracor's website at www.sepracor.com.

Patent No. 7,632,844 Issued on Dec. 15, Assigned to Nycomed for Compound (German Inventors)
US Fed News Service, Including US State News; 12/16/2009; 364 words; ...compound. The inventors were issued U.S. Patent No. 7,632,844 on Dec. 15. The patent has been assigned to Nycomed GmbH, Constance, Germany. According to the abstract released by the U.S. Patent & Trademark Office: "The compounds...

Publication No. WO/2009/147178 Published on Dec. 10, Assigned to Nycomed for Novel Medical (German Inventor)
US Fed News Service, Including US State News; 12/11/2009; 343 words; ...novel medical use of substituted pyridin-2-ylmethylsulphinyl-1h-benzimidazole. The patent has been assigned to Nycomed GmbH, Konstanz, Germany. According to an abstract posted by the World Intellectual Property Organization: "The invention...

Patent No. 7,629,361 Issued on Dec. 8, Assigned to NYCOMED for Salt (German Inventors)
US Fed News Service, Including US State News; 12/9/2009; 366 words; ...developed a salt. The inventors were issued U.S. Patent No. 7,629,361 on Dec. 8. The patent has been assigned to NYCOMED GmbH, Constance. According to the abstract released by the U.S. Patent & Trademark Office: "The invention relates...

Research conducted at N. Nassr and co-authors has provided new information about pharmacokinetics.
Biotech Week; 11/11/2009; 1224 words; ...British Journal of Clinical Pharmacology, 2009;68(4):580-7). For additional information, contact N. Nassr, Nycomed GmbH, 78467 Konstanz, Germany. The publisher's contact information for the British Journal of Clinical Pharmacology...